Filed 2mo ago· Mar 24, 2026
39 days to disclose
Angus S., Jr. King
ISenateMaine
↓sold
Eli Lilly
LLY
$1K-$15K
−5.8% vs S&P 500
Trade dateFeb 13, 2026
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–22 of 22
Filed 4mo ago· Jan 26, 2026
28 days to discloseAngus S., Jr. King
ISenateMaine
↑bought
Eli Lilly
LLY
$1K-$15K
+3.8% vs S&P 500
Trade dateDec 29, 2025
Filed 4mo ago· Jan 16, 2026
18 days to disclose
Markwayne Mullin
RSenateOklahoma
↑bought
Eli Lilly
LLY
$15K-$50K
+2.5% vs S&P 500
Trade dateDec 29, 2025
Filed 5mo ago· Dec 8, 2025
17 days to disclose
John Boozman
RSenateArkansas
↓sold
Eli Lilly
LLY
$1K-$15K
−3.9% vs S&P 500
Trade dateNov 21, 2025
Filed 7mo ago· Nov 4, 2025
11 days to disclose
Shelley Moore Capito
RSenateWest Virginia
↑bought
Eli Lilly
LLY
$1K-$15K
+26.2% vs S&P 500
Trade dateOct 24, 2025
⚑ Pharmaceutical
Filed 8mo ago· Sep 12, 2025
21 days to discloseJohn Boozman
RSenateArkansas
↑bought
Eli Lilly
LLY
$1K-$15K
+40.8% vs S&P 500
Trade dateAug 22, 2025
Filed 8mo ago· Sep 12, 2025
32 days to discloseJohn Boozman
RSenateArkansas
↑bought
Eli Lilly
LLY
$1K-$15K
+52.2% vs S&P 500
Trade dateAug 11, 2025
Filed 9mo ago· Aug 12, 2025
244 days to disclose · 199 past 45-day windowMarkwayne Mullin
RSenateOklahoma
↑bought
Eli Lilly
LLY
$50K-$100K
+28.1% vs S&P 500
Trade dateDec 11, 2024
Filed 1.1y ago· May 15, 2025
30 days to disclose
Tommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
+7.9% vs S&P 500
Trade dateApr 15, 2025
⚑ Pharmaceutical
Filed 1.3y ago· Feb 21, 2025
11 days to disclose
Ron Wyden
DSenateOregon
↓sold
Eli Lilly
LLY
$50K-$100K
+1.5% vs S&P 500
Trade dateFeb 10, 2025
⚑ Pharmaceutical
Filed 1.3y ago· Feb 21, 2025
30 days to discloseRon Wyden
DSenateOregon
↑bought
Eli Lilly
LLY
$50K-$100K
+37.4% vs S&P 500
Trade dateJan 22, 2025
⚑ Pharmaceutical
Filed 1.6y ago· Nov 7, 2024
8 days to disclose
Sheldon Whitehouse
DSenateRhode Island
↑bought
Eli Lilly
LLY
$15K-$50K
+33.9% vs S&P 500
Trade dateOct 30, 2024
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
+23.5% vs S&P 500
Trade dateApr 3, 2024
⚑ Pharmaceutical
Filed 2.3y ago· Feb 14, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
+7.2% vs S&P 500
Trade dateJan 3, 2024
⚑ Pharmaceutical
Filed 2.4y ago· Jan 18, 2024
35 days to discloseSheldon Whitehouse
DSenateRhode Island
↑bought
Eli Lilly
LLY
$1K-$15K
+2.8% vs S&P 500
Trade dateDec 14, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Nov 1, 2023
29 days to discloseMarkwayne Mullin
RSenateOklahoma
↑bought
Eli Lilly
LLY
$1K-$15K
−1.0% vs S&P 500
Trade dateOct 3, 2023
Filed 2.6y ago· Oct 17, 2023
27 days to discloseSheldon Whitehouse
DSenateRhode Island
↑bought
Eli Lilly
LLY
$15K-$50K
−7.6% vs S&P 500
Trade dateSep 20, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Oct 13, 2023
35 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$1K-$15K
+12.5% vs S&P 500
Trade dateSep 8, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Oct 12, 2023
29 days to discloseMarkwayne Mullin
RSenateOklahoma
↑bought
Eli Lilly
LLY
$15K-$50K
−12.3% vs S&P 500
Trade dateSep 13, 2023
Filed 2.7y ago· Oct 4, 2023
21 days to disclose
John R. Curtis
RSenateUtah
↑bought
Eli Lilly
LLY
$1K-$15K
−12.3% vs S&P 500
Trade dateSep 13, 2023
⚑ Pharmaceutical
Filed 4.3y ago· Feb 14, 2022
31 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Eli Lilly
LLY
$15K-$50K
−208.5% vs S&P 500
Trade dateJan 14, 2022
⚑ Pharmaceutical
Filed 5.1y ago· May 2, 2021
381 days to disclose · 336 past 45-day windowDJ
David A Perdue , Jr
—Senate
↓sold
Eli Lilly
LLY
$1K-$15K
Trade dateApr 16, 2020
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Mar 24, 2026 2mo ago | Angus S., Jr. King ISenateMaine | ↓sold | Eli Lilly LLY | Feb 13, 2026 39 days to disclose | Flat·+0.0% −5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 26, 2026 4mo ago | Angus S., Jr. King ISenateMaine | ↑bought | Eli Lilly LLY | Dec 29, 2025 28 days to disclose | Bad buy·−$67-0.8% +3.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 16, 2026 4mo ago | Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Dec 29, 2025 18 days to disclose | Bad buy·−$701-2.2% +2.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 8, 2025 5mo ago | John Boozman RSenateArkansas | ↓sold | Eli Lilly LLY | Nov 21, 2025 17 days to disclose | Flat·+0.0% −3.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 4, 2025 7mo ago | Shelley Moore Capito RSenateWest Virginia | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Oct 24, 2025 11 days to disclose | Good buy·+$2.2K+27.9% +26.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↑bought | Eli Lilly LLY | Aug 22, 2025 21 days to disclose | Good buy·+$3.9K+48.3% +40.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↑bought | Eli Lilly LLY | Aug 11, 2025 32 days to disclose | Good buy·+$5.3K+66.2% +52.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2025 9mo ago | Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Dec 11, 2024 244 days to disclose · 199 past 45-day window | Good buy·+$24.4K+32.6% +28.1% vs S&P 500 | $50K-$100K midpoint $75K |
May 15, 2025 1.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 21, 2025 1.3y ago | Ron Wyden DSenateOregon | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Finance | Feb 10, 2025 11 days to disclose | Flat·+0.0% +1.5% vs S&P 500 | $50K-$100K midpoint $75K |
Feb 21, 2025 1.3y ago | Ron Wyden DSenateOregon | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Finance | Jan 22, 2025 30 days to disclose | Good buy·+$31.4K+41.9% +37.4% vs S&P 500 | $50K-$100K midpoint $75K |
Nov 7, 2024 1.6y ago | Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Oct 30, 2024 8 days to disclose | Good buy·+$11.1K+34.1% +33.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Missed gain·−$4.5K-13.9% +23.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 3, 2024 42 days to disclose | Flat·+0.0% +7.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 18, 2024 2.4y ago | Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 14, 2023 35 days to disclose | Good buy·+$4.3K+54.1% +2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Oct 3, 2023 29 days to disclose | Good buy·+$5.5K+68.3% −1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 17, 2023 2.6y ago | Sheldon Whitehouse DSenateRhode Island | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 20, 2023 27 days to disclose | Good buy·+$17.9K+55.2% −7.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 13, 2023 2.6y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Sep 8, 2023 35 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 12, 2023 2.6y ago | Markwayne Mullin RSenateOklahoma | ↑bought | Eli Lilly LLY | Sep 13, 2023 29 days to disclose | Good buy·+$15.5K+47.6% −12.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 4, 2023 2.7y ago | John R. Curtis RSenateUtah | ↑bought | Eli Lilly LLY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 13, 2023 21 days to disclose | Good buy·+$3.8K+47.6% −12.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2022 4.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Eli Lilly LLY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 14, 2022 31 days to disclose | Missed gain·−$85.2K-262.1% −208.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 2, 2021 5.1y ago | DJ David A Perdue , Jr —Senate | ↓sold | Eli Lilly LLY | Apr 16, 2020 381 days to disclose · 336 past 45-day window | price pending | $1K-$15K midpoint $8K |